Amphastar Pharmaceuticals Inc (NAS:AMPH)
$ 46.09 -7.31 (-13.69%) Market Cap: 2.26 Bil Enterprise Value: 3.02 Bil PE Ratio: 14.73 PB Ratio: 3.10 GF Score: 88/100

Q3 2021 Amphastar Pharmaceuticals Inc Earnings Call Transcript

Nov 08, 2021 / 10:00PM GMT
Release Date Price: $19.95 (-0.65%)
Dan Dischner
Amphastar Pharmaceuticals, Inc. - VP of Corporate Communications

I'd like to thank everybody for joining us this afternoon. As you have seen, Amphastar recently reported our financial results and I am pleased to announce that the upward momentum from last quarter's strong execution was sustainable and carried over into the third quarter.

With that said, we saw another great quarter of top line and bottom line growth, as we remain generally insulated from the typical challenges facing our sector in the pharmaceutical space. Again, this is another validating quarter, highlighting the importance of Amphastar's core strengths as our vision, strategy and vertical integrated platforms continue to deliver on our growing commercial proficiencies.

After my portion, I will turn the call over to our CFO and Executive Vice President of Finance, Bill Peters, who will provide an update on the company's financials. After Bill's remarks, we'll move on to the Q&A portion of the call where Tony Marrs, Senior Vice President of Regulatory Affairs and Clinical Operations, Bill and myself

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot